In the past week, TTI stock has gone down by -7.49%, with a monthly gain of 24.91% and a quarterly plunge of -1.98%. The volatility ratio for the week is 6.28%, and the volatility levels for the last 30 days are 6.31% for Tetra Technologies, Inc The simple moving average for the past 20 days is 5.75% for TTI’s stock, with a 0.68% simple moving average for the past 200 days.
Is It Worth Investing in Tetra Technologies, Inc (NYSE: TTI) Right Now?
Tetra Technologies, Inc (NYSE: TTI) has a higher price-to-earnings ratio of 4.12x compared to its average ratio. TTI has 36-month beta value of 1.35. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TTI is 125.07M, and currently, short sellers hold a 2.91% ratio of that float. The average trading volume of TTI on June 27, 2025 was 1.66M shares.
TTI) stock’s latest price update
Tetra Technologies, Inc (NYSE: TTI)’s stock price has increased by 4.22 compared to its previous closing price of 3.32. However, the company has seen a -7.49% decrease in its stock price over the last five trading sessions. newsfilecorp.com reported 2025-06-25 that San Diego, California–(Newsfile Corp. – June 25, 2025) – Thiogenesis Therapeutics, Inc. (TSXV: TTI) (OTCQX: TTIPF), a clinical-stage biopharmaceutical company developing next-generation thiol-based therapies for mitochondrial disease and pediatric metabolic conditions, today announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) has provided scientific advice supporting the company’s submission of an Investigational Medicinal Product Dossier (“IMPD”) for a Phase 2a clinical trial in pediatric patients with metabolic dysfunction-associated steatohepatitis (“MASH”). This exploratory trial will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic effects of TTI-0102, a third-generation disulfide prodrug of cysteamine, in children ages 10 to 17 with biopsy-confirmed MASH – and with a relevant level of disease activity, including at least fibrosis stage 2.
Analysts’ Opinion of TTI
Many brokerage firms have already submitted their reports for TTI stocks, with The Benchmark Company repeating the rating for TTI by listing it as a “Buy.” The predicted price for TTI in the upcoming period, according to The Benchmark Company is $8 based on the research report published on September 28, 2023 of the previous year 2023.
Johnson Rice, on the other hand, stated in their research note that they expect to see TTI reach a price target of $7. The rating they have provided for TTI stocks is “Buy” according to the report published on June 24th, 2022.
Stifel gave a rating of “Buy” to TTI, setting the target price at $3 in the report published on February 03rd of the previous year.
TTI Trading at 17.24% from the 50-Day Moving Average
After a stumble in the market that brought TTI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.42% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TTI starting from Hallead Kurt, who purchase 72,633 shares at the price of $3.39 back on Jun 11 ’25. After this action, Hallead Kurt now owns 148,764 shares of Tetra Technologies, Inc, valued at $246,226 using the latest closing price.
Hallead Kurt, the VP-Treasurer & IR of Tetra Technologies, Inc, purchase 76,131 shares at $2.74 during a trade that took place back on May 05 ’25, which means that Hallead Kurt is holding 76,131 shares at $208,599 based on the most recent closing price.
Stock Fundamentals for TTI
Current profitability levels for the company are sitting at:
- 0.1 for the present operating margin
- 0.25 for the gross margin
The net margin for Tetra Technologies, Inc stands at 0.18. The total capital return value is set at -0.52. Equity return is now at value 55.55, with 21.12 for asset returns.
Based on Tetra Technologies, Inc (TTI), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.79. The interest coverage ratio of the stock is 2.82.
Currently, EBITDA for the company is 86.93 million with net debt to EBITDA at 2.39. When we switch over and look at the enterprise to sales, we see a ratio of 1.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.54.
Conclusion
To put it simply, Tetra Technologies, Inc (TTI) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
